Frost & Sullivan is conducting research on behalf of 3M Life Sciences to assess their newest anion exchange polishing membrane; 3M™ Polisher ST. As a downstream mAb processing expert, we invite you to participate in this trial to help evaluate the next generation of anion exchange chromatography for the entire bio-pharmaceutical industry.

The Early Access Program will be for a Next Generation Downstream Processing Single Use Polishing AEX Membrane Chromatography designed for HCP and DNA reduction while simultaneously mitigating viral risk in a mammalian cell culture manufacturing process.

To kick off the Early Access Program, we are hosting a web conference (click on Participant RSVP Tab to confirm). During the web conference, a comprehensive overview of the 3M Polisher ST will be provided as well as timeline for the Early Access Program. Participation in the Early Access Program allows you early beta testing of the product and a forum to provide feedback throughout the study to our analyst. Our third party research of the 3M Polisher ST will maintain the objectivity and integrity of the study to determine its functionality and reliability before going to market.

The Early Access Program includes:

• series testing for instrument & non-instrument users
• 3 surveys
• 3 blind virtual discussions
• one on one interviews with analyst
  
  

Our Vice President, Global Head of Life Sciences, Nitin Naik, will be conducting interviews and hosting virtual discussions throughout the study. Over the course of the program he will collect feedback to provide a non-biased report of 3M Polisher ST.